These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 19818304)

  • 1. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
    Cusi K
    Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
    Larter CZ; Chitturi S; Heydet D; Farrell GC
    J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From a glucocentric to a lipocentric approach towards metabolic syndrome.
    Mittra S; Bansal VS; Bhatnagar PK
    Drug Discov Today; 2008 Mar; 13(5-6):211-8. PubMed ID: 18342796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
    Rolo AP; Teodoro JS; Palmeira CM
    Free Radic Biol Med; 2012 Jan; 52(1):59-69. PubMed ID: 22064361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S; Muratore C; Craxì A
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and steatosis in humans.
    Capeau J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
    Tessari P; Coracina A; Cosma A; Tiengo A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J; Choi SS; Diehl AM
    Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
    Roden M
    Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):335-48. PubMed ID: 16932311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acids and insulin resistance.
    Delarue J; Magnan C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW; Cooney GJ
    Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.